Effective gut health management requires more than a single approach. This presentation explores three key considerations. First, gut health should address both microbial control and host resilience through antimicrobial and non-antimicrobial strategies. Second, delivery technology is critical to ensure active compounds reach the intended site of action at effective concentrations. Third, efficacy should be supported by a robust validation pathway, progressing from in vitro screening and challenge studies to independent and commercial validation. Together, these elements provide a systematic approach to developing effective gut health solutions.